Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects

NCT02817659 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT02817659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02817659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects
Lead sponsor
AdventHealth Translational Research Institute
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 1, 2016
Completion date
December 31, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity